Cargando…
Advances in the Treatment of Polycythemia Vera: Trends in Disease Management
Treatment modalities for polycythemia vera (PV) have evolved over time. Phlebotomy and low-dose aspirin suffice in low-risk patients, but cytoreductive therapies are indicated in all high-risk patients (age ≥ 65 years or those with a history of PV-related thrombotic event) and may be considered for...
Autores principales: | Arya, Yajur, Syal, Arshi, Gupta, Monica, Gaba, Saurabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084584/ https://www.ncbi.nlm.nih.gov/pubmed/33936902 http://dx.doi.org/10.7759/cureus.14193 |
Ejemplares similares
-
Isolated Splenic Tuberculosis: A Diagnostic Conundrum
por: Grover, Sahil, et al.
Publicado: (2021) -
Idiopathic Symmetrical Peripheral Gangrene: A Rare Clinical Entity
por: Gaba, Saurabh, et al.
Publicado: (2021) -
Helminthic Infection in the Background of Active Pulmonary Tuberculosis: An Underreported Co-infection
por: Syal, Arshi, et al.
Publicado: (2021) -
Splenic and Portal Vein Thrombosis With Concurrent Splenic Infarction: A Rare Manifestation of Essential Thrombocythemia
por: Gulia, Manisha, et al.
Publicado: (2021) -
JAK2 and TET2 Mutation in Polycythemia Vera
por: Padda, Jaskamal, et al.
Publicado: (2021)